Disease Modifying Therapies Continue To Drive Up Health Care Cost Among Individuals With Multiple Sclerosis

ConclusionsAnnual health care costs for MS patients increased rapidly between 2011 and 2015, almost entirely due to the cost of DMTs. Older drugs as well as newly approved DMTs both drove this trend.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research